Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease
Clinical trial NCT03252535 · COMPLETED
Trial details
- NCT number
- NCT03252535
- Sponsor
- Azidus Brasil
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2021-03-23
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.